51. Teaching and Learning Pharmacovigilance

  1. Elizabeth B. Andrews PhD, MPH, FISPE2 and
  2. Nicholas Moore MD, PhD, FRCP(Edin), FISPE3
  1. Frank May

Published Online: 4 APR 2014

DOI: 10.1002/9781118820186.ch51

Mann's Pharmacovigilance

Mann's Pharmacovigilance

How to Cite

May, F. (2014) Teaching and Learning Pharmacovigilance, in Mann's Pharmacovigilance (eds E. B. Andrews and N. Moore), John Wiley & Sons, Ltd, Oxford, UK. doi: 10.1002/9781118820186.ch51

Editor Information

  1. 2

    Vice President, Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA

  2. 3

    Professor of Clinical Pharmacology, Service Hospitalo-Universitaire de Pharmacologie, Bordeaux, France

Author Information

  1. Drug and Therapeutics Information Service – DATIS, Repatriation General Hospital, Daw Park, SA, Australia

Publication History

  1. Published Online: 4 APR 2014
  2. Published Print: 1 APR 2014

ISBN Information

Print ISBN: 9780470671047

Online ISBN: 9781118820186



  • education;
  • learning;
  • medication;
  • pharmacovigilance;
  • safety;
  • uncertainty;
  • error;
  • benefit;
  • risk;
  • harm


There are two closely connected dimensions of educational need associated with the field of pharmacovigilance. The principal dimension is that of the clinical practitioner who needs knowledge, understanding, and wisdom about effects of pharmaceuticals in their day-to-day healthcare practice. The secondary dimension is that of professionals in the field who must amass and evaluate emerging evidence from broad populations exposed to pharmacotherapies. The healthcare practitioner needs to keep abreast of new knowledge about benefits and possible harms associated with the pharmacotherapies they customarily use. On the other hand, the professional pharmacovigilist needs to develop and maintain discriminating skills for the same evolving clinical knowledge, as well as mastery of the increasingly complex systems of signal generation, systematic investigation of signal meaning, and effective communication back to the public and healthcare practitioners.